Evidence map›Paper›PMID 40259836›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2025

Prognostic value of invasive versus echocardiography-derived aortic gradient in patients undergoing TAVI.

Mark M P van den Dorpel, Sraman Chatterjee, Rik Adrichem, Sarah Verhemel, Isabella Kardys, Rutger-Jan Nuis, Joost Daemen, Claire Ben Ren, Alexander Hirsch, Marcel L Geleijnse and 1 more

Abstract readComparative Study
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Invasive and echocardiographic gradients of self- and balloon-expandable valves in failing aortic bioprostheses.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Impact of Anticoagulation on Valve Hemodynamics Following Transcatheter Valve-In-Valve Implantation.Journal of the Society for Cardiovascular Angiography & Interventions · 2026
    Article
  8. Letter: When gradients diverge: integrating invasive assessment into post-TAVI surveillance.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Article
  9. The challenge of interpreting comparative TAVI studies.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Article
  10. From invasive gradients to pressure recovery: rethinking long-standing paradigms.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mark M P van den DorpelDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Sraman ChatterjeeDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Rik AdrichemDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Sarah VerhemelDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Isabella KardysDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Rutger-Jan NuisDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Joost DaemenDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Claire Ben RenDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Alexander HirschDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Marcel L GeleijnseDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Nicolas M Van MieghemDepartment of Cardiology, Cardiovascular Institute, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent studies report a discordance between invasive and echocardiography-derived gradients after transcatheter aortic valve implantation (TAVI) with balloon-expandable (BEV) and self-expanding valves (SEV). There are limited data on the determinants and clinical implications of this discordance.

aimsWe aimed to examine the prognostic value of invasive and echocardiography-derived gradients after implantation of SEV and BEV and to compare gradients for SEV versus BEV.

methodsWe performed a retrospective, propensity score-matched study. Invasive measurements were obtained before and immediately after TAVI. Echocardiography was performed before and within 24 hours after TAVI, and at 1 year. Clinical outcomes were assessed at 30 days, 1 year, and 2 years.

resultsThe 1:1 propensity score matching resulted in 436 matched pairs (436 SAPIEN 3 and 436 Evolut). Invasive gradients post-TAVI independently predicted higher risk for all-cause mortality at 30 days, 1 year and 2 years as a continuous variable (hazard ratio [HR] 1.07, 95% confidence interval [CI]: 1.00-1.14; p=0.038; HR 1.06, 95% CI: 1.01-1.11; p=0.007; HR 1.05, 95% CI: 1.01-1.09; p=0.011, respectively) and by using >10 mmHg as a cutoff (HR 1.95, 95% CI: 1.13-4.78; p=0.028; HR 1.91, 95% CI: 1.11-3.65; p=0.030; HR 1.61, 95% CI: 1.03-2.96; p=0.021, respectively), but echocardiography-derived gradients did not (HR 1.13, 95% CI: 0.87-1.75; p=0.247; HR 1.02, 95% CI: 0.95-1.10; p=0.639; HR 0.99, 95% CI: 0.94-1.07; p=0.979, respectively). Mean gradients before and after TAVI were higher by echocardiography than by invasive measurements. The difference was more pronounced after implantation with BEV than SEV (7.0 [25th-75th percentile: 4.0-11.0] mmHg vs 5.0 [2.0-7.0] mmHg; p<0.001). Smaller valve size, higher ejection fraction and higher stroke volume amplified the discordance. Invasive mean gradients were similar after SEV and BEV (3.0 [0.0-6.0] mmHg vs 3.0 [0.0-6.0] mmHg; p=0.166), but echo-derived mean gradients were lower after SEV versus BEV (8.0 [6.0-11.0] mmHg vs 11.0 [8.0-14.0] mmHg; p<0.001).

conclusionsOnly invasively measured but not echocardiography-derived transvalvular mean gradients correlate with 30-day, 1-year and 2-year mortality. Aortic gradient measurements are higher by echocardiography than by invasive assessment and more so for BEV than SEV. Smaller valve size, higher ejection fraction and higher stroke volume increase this discordance between echocardiography and invasive assessment.

Indexed as

Aortic ValveAortic Valve StenosisEchocardiographyTranscatheter Aortic Valve ReplacementAgedAged, 80 and overFemaleHeart Valve ProsthesisHumansMalePrognosisPropensity ScoreRetrospective StudiesTreatment Outcome

Identifiers

PMID40259836
PMCPMC11995293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.